These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38171649)

  • 1. Is adamgammadex the brother of sugammadex or the next generation of reversal agent?
    Hunter JM; Sneyd JR
    Br J Anaesth; 2024 Jan; 132(1):15-17. PubMed ID: 38171649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block.
    Zhang Y; Jiang Y; Lei Q; Li C; Jin S; Wang Q; Huang Y; Li Y; Hong Y; Wang S; Lin H; Li H; Ou Y; Zou X; Sun Q; Guo Q; Chen Z; Min S; Qi Y; Jie Q; Liu J; Liu B; Zhang W
    Br J Anaesth; 2024 Jan; 132(1):45-52. PubMed ID: 38007377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adamgammadex in patients to reverse a moderate rocuronium-induced neuromuscular block.
    Jiang YY; Zhang YJ; Zhu ZQ; Huang YD; Zhou DC; Liu JC; Li CY; Liu J; Liu B; Zhang WS
    Br J Clin Pharmacol; 2022 Aug; 88(8):3760-3770. PubMed ID: 35304924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report.
    Kim GH; Choi WS; Kim JE; Yun MJ; Koo MS; Kwon M; Seo H
    Korean J Anesthesiol; 2019 Oct; 72(5):495-499. PubMed ID: 30481948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency and Safety of the Selective Relaxant Binding Agent Adamgammadex Sodium for Reversing Rocuronium-Induced Deep Neuromuscular Block: A Single-Center, Open-Label, Dose-Finding, and Phase IIa Study.
    Zhao Y; Chen S; Huai X; Yu Z; Qi Y; Qing J; Yu W; Su D
    Front Med (Lausanne); 2021; 8():697395. PubMed ID: 34513870
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety, tolerability, and pharmacokinetics of adamgammadex sodium, a novel agent to reverse the action of rocuronium and vecuronium, in healthy volunteers.
    Jiang Y; Zhang Y; Xiang S; Zhao W; Liu J; Zhang W
    Eur J Pharm Sci; 2020 Jan; 141():105134. PubMed ID: 31678425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial.
    Jiang Y; Zhang Y; Zhu Z; Huang Y; Zhou D; Liu J; Li C; Chen X; Kang D; Wang S; Liu J; Liu B; Zhang W
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sugammadex in the treatment of anaphylaxis due to rocuronium in children: Extrapolation from adult and animal reports.
    Ghimire A; Olbrecht VA; Tobias JD
    Paediatr Anaesth; 2022 Jun; 32(6):706-715. PubMed ID: 35212434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis.
    Ji SH; Huh KY; Oh J; Jeong HJ; Jang YE; Kim EH; Lee JH; Kim JT; Kim HS
    Clin Transl Sci; 2023 Jan; 16(1):92-103. PubMed ID: 36181377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex: a review of its use in anaesthetic practice.
    Yang LP; Keam SJ
    Drugs; 2009; 69(7):919-42. PubMed ID: 19441874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
    Donati F
    Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.